COVID-19 Clinical Best Practice – AASLD expert panel consensus statement

COVID-19 Clinical Best Practice – AASLD expert panel consensus statement Oren K. Fix Bilal Hameed Robert J. Fontana Ryan M. Kwok Brendan M. McGuire David C. Mulligan Daniel S. Pratt Mark W. Russo Michael L. Schilsky Elizabeth C. Verna Rohit Loomba David E. Cohen Jorge A. Bezerra K. Rajender Reddy Raymond T. Chung Hepatology doi: 10.1002/HEP.31281 This document provides data on what is currently known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. The aim is to provide a template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and healthcare providers. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

COVID-19 and Liver Dysfunction – JCTH

COVID-19 and Liver Dysfunction – JCTH Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, et al. J Clin Transl Hepatol 2020;8(1):18–24. doi: 10.14218/JCTH.2020.00018. COVID-19 and liver dysfunction: Current insights and emergent therapeutic strategies

Implication of NAFLD in patients with COVID-19 – JHEP

Implication of NAFLD in patients with COVID-19 – JHEP2020 Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau Journal of Hepatology (2020), doi: https://doi.org/10.1016/j.jhep.2020.03.044. Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis